[Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
D000368:Aged; D002395:Catecholamines / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002395:Catecholamines; D014665:Vasodilator Agents; D010208:Papaverine
Klinische Prüfung eines neuen Vasodilatans (Dilydrin) bei zerebralen Durchblutungsstörungen und apoplektischen Insulten.